Stem Cell Research (Aug 2022)

Generation of an induced pluripotent stem cell line from a 3-month-old nemaline myopathy patient with a heterozygous dominant c.515C > A (p.Ala172Glu) variant in the ACTA1 gene

  • Joshua S. Clayton,
  • Isabella Suleski,
  • Christina Vo,
  • Robert Smith,
  • Carolin K. Scriba,
  • Safaa Saker,
  • Thierry Larmonier,
  • Edoardo Malfatti,
  • Norma B. Romero,
  • Peter J. Houweling,
  • Kristen J. Nowak,
  • Gianina Ravenscroft,
  • Nigel G. Laing,
  • Rhonda L. Taylor

Journal volume & issue
Vol. 63
p. 102829

Abstract

Read online

Variants in the ACTA1 gene are a common cause of nemaline myopathy (NM); a muscle disease that typically presents at birth or early childhood with hypotonia and muscle weakness. Here, we generated an induced pluripotent stem cell line (iPSC) from lymphoblastoid cells of a 3-month-old female patient with intermediate NM caused by a dominant ACTA1 variant (c.515C > A (p.Ala172Glu)). iPSCs showed typical morphology, expressed pluripotency markers, demonstrated trilineage differentiation potential, and had a normal karyotype. This line complements our previously published ACTA1 iPSC lines derived from patients with typical and severe NM.